Klin Farmakol Farm. 2007;21(2):62-66

Nutritional support in terminal care

Dana Hrnčiariková1, Michal Hrnčiarik2, Božena Jurašková1, Zdeněk Zadák3
1 Klinika gerontologická a metabolická, FN Hradec Králové
2 Plicní klinika FN, Hradec Králové
3 Centrum pro vědu a výzkum FN a LF UK v Hradci Králové

The object of terminal care are patients in end-stage oncological and non-oncological illnesses (chronic cardiac failure, COPD, neurodegenerative diseases etc.). In the following article we focuse first of all on terminal oncological diseases. Causes of neoplastic cachexia are not exactly clarified. Anorexia, local tumor proliferation and pathological increase of metabolic processes in the organism participate in tumor cachexia. Indications and contraindications of nutritional support in terminal care are not easy and are pursued by many ethical aspects. We always have to choose individual approach in cooperation with patient. Nutritional support should improve the quality of life not prolong the suffering. The aim of this work is to show specific problems of nutrition in terminal care.

Keywords: nutritional support, terminal care, megestrol acetat, neoplastic cachexia, oncological patient

Published: October 1, 2007  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Hrnčiariková D, Hrnčiarik M, Jurašková B, Zadák Z. Nutritional support in terminal care. Klin Farmakol Farm. 2007;21(2):62-66.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Vorlíček J. Paliativní medicína. 2. vydání. Praha: GRADA Publishing, 2004: 537.
    2. Adam Z, Vorlíček J, Koptíková J. Obecná onkologie a podpůrná léčba. 1. vydání. Praha: GRADA Publishing, 2003: 787.
    3. Klener P. Klinická onkologie. 1. vydání. Praha: Galén a Karolinum, 2002: 686.
    4. Skála B, Sláma O, Vorlíček J, Misconiová B. Paliativní péče o pacienty v terminálním stádiu nemoci. Doporučený diagnostický a léčebný postup pro všeobecné praktické lékaře. Praha: Společnost všeobecného lékařství ČLS JEP, 2005: 9.
    5. www.umirani.cz
    6. Tomíška M, Vorlíček J. Nutriční podpora onkologických nemocných. Postgrad med 2002; 2: 143-150.
    7. www.hospice.cz
    8. Beneš P. Apetitová stimulancia v léčbě nádorové anorexie a kachexie. Diabet metab endokrin výživa 1998; 1 (4): 186-190.
    9. Tomíška M. Zkušenosti s megestrolacetátem v léčbě syndromu anorexie/kachexie. Literární přehled i vlastní zkušenost. Klin výživa intenz metab péče 2002; (1): 21-26.
    10. Tomíška M, Kubešová H, Tomíšková M, Salajka F, Vorlíček J. Perorální suspenze megestrol acetátu v léčbě anorexie u pokročilého nádorového onemocnění. Klin onkol 2002; 15 (2): 67-71.
    11. Zimovjanová M, Chroust K. Megestrol acetát v léčbě syndromu anorexie a kachexie u pacientů s nádorovým onemocněním. Medicína po promoci 2005; 6 (10): 74-76.
    12. Casarett D, Kapo J, Caplan A. Appropriate Use of Artificial Nutrition and Hydration - Fundamental Principles and Recommendations. N Engl J Med 2005; 353: 2607-2612. Go to original source... Go to PubMed...
    13. Gillick MR. Rethinking the Role of Tube Feeding in Patients with Advanced Dementia. N Engl J Med 2000; 342: 206-210. Go to original source... Go to PubMed...
    14. Zadák Z. Výživa v intenzivní péči. 1. vydání. Praha: GRADA Publishing, 2002: 487.
    15. MacFie J. Ethics of artificial nutrition. Nutrition 2006; 34 (12): 548-550. Go to original source...
    16. Van Der Hulst RR, Deutz NE, Von Meyenfeldt MF, Elbers JM, Stockbrügger RW, Soeters PB. Decrease of mucosal glutamine concentration in the nutritionally depleted patient. Clin Nutr 1994; 13: 228-233. Go to original source... Go to PubMed...
    17. Calder PC. Glutamine and the immune systém. Clin Nutr 1994;13: 2-8. Go to original source... Go to PubMed...

    Return to the content


    Clinical Pharmacology and Pharmacy

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.